Zenas BioPharma, Inc.

ZBIO

—

Advanced chart & tools →

Zenas BioPharma, Inc.ZBIO

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-8.44

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$10.00M

Net income

$-377.74M

Net margin

-3777.4%

Gross margin

—

Dividends & financials

Zenas BioPharma, Inc. (ZBIO) reported revenue of $10.00M and net income of $-377.74M, or $-8.44 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.